Nicotine: therapeutic potential for the treatment of ulcerative colitis

Bibliography

• MOSMANN TR, CHERWINSKI HM, BOND MW, GIEDLIN MA,COFFMAN RL: Two types of murine helper T-cell clone. I. Definition according to the profiles of lymphokine activities and secreted proteins. J. Immunol (1986) 136:2348–2357.
   Google Scholar
• MOSMANN TR, SAD S: The expanding universe of T-cellsubsets: Thl, Th2 and more. Immunol. Today (1996) 17:138–146.
   PubMedGoogle Scholar
• ROBINSON DS, HAMID Q, YING S et al.: Predominant Th2-like bronchoalveolar T-lymphocyte population in atopic asthma. New Engl. J. Med. (1992) 326:298–304.
   PubMed Web of Science ®Google Scholar
• ROBINSON D, HAMID Q, BENTLEY A et al.: Activation of CD4+ T-cells, increased Th2 type cytokine mRNA ex-pression, and eosinophil recruitment in bronchoalveo-la r lavage after allergen inhalation challenge in patients with atopic asthma.Allergy Clin. Immunol. (1993)92:313–324.
   Google Scholar
• ROBINSON DS, YING S, BENTLEY AM et al.: Relationshipamong numbers of bronchoalveolar lavage cells ex-pressing messenger ribonucleic acid for cytokines, asthma symptoms, and airway methacholine respon-siveness in atopic asthma J. Allergy Clin. Immunol. (1993) 92:397–403.
   Google Scholar
• ROBINSON DS, TSICOPOULOS A, MENG Q et al.: Increasedinterleukin-10 messenger RNA expression in atopic allergy and asthma. Am. J. Resp. Cell Mot Biol. (1996) 14:113–117.
   Google Scholar
• HUANG S-K, XIAO H-Q, KLEINE-TEBBE J et al.: IL-13 expression at the sites of allergen challenge in patients with asthma. J. Immunol. (1995) 155:2688–2694.
   PubMed Web of Science ®Google Scholar
• HAMID Q, AZZAWI M, YING S et al: Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma. J. Clin. Invest (1991) 87:1541–1546.
   PubMed Web of Science ®Google Scholar
• HAMID Q, AZZAWI M, YING S et al.: Interleukin-5 mRNA in mucosal bronchial biopsies from asthmatic subjects. Int. Arch. Allergy Appl. Immunol. (1991) 94:169–170.
   Google Scholar
• BENTLEY AM, MENG Q, ROBINSON DS et al.: Increases in activated T-lymphocytes, eosinophils, and cytokine mRNA expression for IL-5 and GMCSF inbronchial biopsies after allergen inhalation challenge in atopic asthmatics. Am. J. Resp. Cell Mot Biol. (1993) 8:35–42.
   Google Scholar
• TILL S, U B, DURHAM S et al.: Secretion of eosinophil-ac-tive cytokines interleukin-5, granulocyte/macrophage colony-stimulating factor and interleukin-3 by bron-choalveolar lavage CD4+ and CD8+ T-cell lines in atopic asthmatics, and atopic and non-atopic controls. Eur. Immunol. (1995) 25:2727–2731.
   Google Scholar
• KONNO S, GONOKAMI Y, KUROKAWA M et al.: Cytokine concentrations in sputum of asthmatic patients. Int Arch. Allergy Immunol. (1996) 109:73–78.
   PubMed Web of Science ®Google Scholar
• WALKER C, BODE E, BOER L et al.: Allergic and non-al-lergic asthmatics have distinct patterns of T-cell activa-tion and cytokine production in peripheral blood and bronchoalveolar lavage. Am. Rev. Resp. Dis. (1992) 146:109–115.
   PubMed Web of Science ®Google Scholar
• RICCI M, ROSSI O, MATUCCI A: The importance of Th2-like cells in the pathogenesis of airway allergic inflam-mation. Clin. Exp. Allergy (1993) 23:360–369.
   PubMed Web of Science ®Google Scholar
• MARTIN LB, KITA H, LEIFERMAN KM, GLEICH GJ: Eosino-phils in allergy: role in disease, degranulation, and cytokines. Int Arch. Allergy (1996) 109:207–215.
   PubMed Web of Science ®Google Scholar
• GASCAN H, GAUCHAT JF, RONCAROLO MD et al.: Human B-cell clones canbe inducedto proliferate and to switch to IgE and IgG4 synthesis by interleukin-4 and a signal provided by activated CD4 T-cell clones. Clin. Exp. Allergy (1993) 23:360–369.
   Google Scholar
• ZURAWSKI G, DE VRIES JE: Interleukin-13, an inter-leukin-4-like cytokine that acts on monocytes and B-cells, but not on T-cells. Immunol. Today (1994) 15:19–26.
   PubMedGoogle Scholar
• SAITO H, HATAKE K, DVORAK AM et al.: Selective differ-entiation and proliferation of hematopoietic cells in-duced by recombinant human interleukins. Proc. Natl. Acad. Sci. USA (1988) 85:2288–2292.
   Google Scholar
• CLUTTERBUCK EK, HIRST EMA, SANDERSON CJ: Humaninterleukin-5 (11-5) upregulates the production of eos-inophils in human bone marrow cultures: comparison and interaction with IL-1, 11-3, 11-6, and GM-CSF. Blood (1989) 73:1504–1512.
   PubMed Web of Science ®Google Scholar
• YAMAGUCHI Y, SUDA T, SUDA J et at: Purified inter-leukin-5 supports the terminal differentiation and pro-liferation of eosinophilic precursors. J. Exp. Med. (1988) 167:43–56.
   PubMed Web of Science ®Google Scholar
• STERN M, MEAGHER L, SAVILL J, HASLETT C: Apoptosis in human eosinophils. Programmed cell death in the eosinophil leads to phagocytosis by macrophages and is modulated by IL-5. Immunol. (1992) 148:3543–3549.
   Google Scholar
• OHNISHI T, SUR S, COLLIN DS etat: Eosinophil survival activity identified as interleukin-5 is associated with eosinophil recruitment and degranulation and lung injury twenty-four hours after segmental antigen lung challenge. J. Allergy Clin. Immunol. (1993) 92:607–615.
   PubMed Web of Science ®Google Scholar
• FUJISAWA T, ABU-GHAZALEH R, KITA H, SANDERSON CJ, GLEICH GJ: Regulatory effects of cytokines on eosino-phil degranulation. j Immunol. (1990) 44:642–646.
   Google Scholar
• WALSH GM, HARTNEL A, WARDLAW AJ et al.: IL-5 en-hances the in vitroadhesion of human eosinophils, but not neutrophils, in a leukocyte integrin (CD11/18)-de-pendent manner. Immunology (1990) 71:258–265.
   PubMed Web of Science ®Google Scholar
• LOPEZ AF, SANDERSON CJ, GAMBLE JR et al.: Recombi-nant human interleukin-5 is a selective activator of human eosinophil function. J. Exp. Med. (1988) 167:219–224.
   Google Scholar
• YAKOTA T, COFFMAN RL, HAGIWARA H et at: Isolationand characterization of lymphokine cDNA clones en-coding mouse and human IgA-enhancing factor and eosinophil colony-stimulating factor activities: rela-tionship to interleukin-5. Proc. Natl. Acad. Sci. USA (1987) 84:7388–7392.
   PubMed Web of Science ®Google Scholar
• ABU-GHAZALEH RI, FUJISAWA T, MESTECKY J, KYLE RA, GLEICH GJ: IgA-induced eosinophil degranulation. J. Immunol. (1989) 142:2393–2400.
   PubMed Web of Science ®Google Scholar
• BRUSSELLE G, KIPS J, JOOS G, BLUETHMANN H, PAUVVELS R: Allergen-induced airway inflammation and bron-chial responsiveness in wild-type and inter leukin-4-de-ficient mice. Am. J Resp. Cell Mol. Biol. (1995) 12:254–259.
   PubMed Web of Science ®Google Scholar
• CORRY DB, FOLKESSON HG, WARNOCK ML et al.: Inter-leukin-4, but not interleukin-5 or eosinophils, is re-quired in a murine model of acute airway hyper-reactivity. J Exp. Med. (1996) 183:109–117.
   PubMed Web of Science ®Google Scholar
• SWAIN SL, WEINBERG AD, ENGLISH M, HUSTON G: IL-4 directs the development of Th2-like helper effectors. J. Immunol. (1990) 145:3796–3806.
   PubMed Web of Science ®Google Scholar
• PAR RONCHI P, DE CARLI M, MANETTIR et at: IL-4 and IFN(a and y) excite opposite regulatory effects on the development of cytolytic potential by Thl or Th2 hu-man T-cell clones. J. Immunol. (1992) 149:2977–2983.
   PubMed Web of Science ®Google Scholar
• KUNG TT, STELTS DM, ZURCHER JA eta].: Involvement ofIL-5 in a murine model of allergic pulmonary inflam-mation: prophylactic and therapeutic effect of an anti-IL-5 antibody. Am. J. Resp. Cell Mot Biol. (1995) 13:360–365.
   Google Scholar
• FOSTER PS, HOGAN SP, RAMSAY AJ, MATTHAEI KI, YOUNG IG: Interleukin-5 deficiency abolishes eosino-philia, airways hyper-reactivity, and lung damage in a mouse asthma model. J. Exp. Med. (1996) 183:195–201.
   PubMed Web of Science ®Google Scholar
• DRAZEN JM, ARM JP, AUSTEN KF: Sorting out the cytoki-nes of asthma. J. Exp. Med. (1996) 183:1–5.
   PubMed Web of Science ®Google Scholar
• HSIEH C-S, MACATONIA SE, O'GARRA A, MURPHY KM: T-cell genetic background determines T-helper pheno-type development in vitro. J. Exp. Med. (1995) 181:713–721.
   PubMed Web of Science ®Google Scholar
• FIORENTINO DF, BOND MW, MOSMANN TR: Two types of mouse T-helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Thl clones. J. Exp. Med. (1989) 170:2081–2095.
   Google Scholar
• GAJEWSKI TF, FITCH FW: Anti-proliferative effect of IFN-y in immune regulation. L IFN-y inhibits the prolif-eration of Th2 but not Thl murine helper T-lymphocyte clones. J. Immunol. (1988) 140:4245–4252.
   Google Scholar
• COYLE AJ, WAGNER K, BERTRAND C et al: Central role of immunoglobulinE in the induction of lungeosinophil infiltration and T-helper 2 cell cytokine production: inhibition by a non-anaphylactogenic anti-IgE antibody. J. Exp. Med. (1996) 183:1303–1310.
   PubMed Web of Science ®Google Scholar
• PUNNONEN J, AVERSA G, COCKS BG eta].: Interleukin-13 induces interleukin 4-independent IgG4 and IgE syn-thesis and CD23 expres sion by human B-cells. Proc. Natl. Acad. Sci. USA (1993) 90:3730–3734.
   Google Scholar
• D'ANDREA A, RENGARAJUM, VALIANTE NM et al: Produc-tion of natural killer cell stimulatory factor (inter-leukin-12) by peripheral blood mononuclear cells. J. Exp. Med. (1992) 176:1387–1398.
   PubMed Web of Science ®Google Scholar
• CASSATELLA MA: The production of cytokines by poly-morphonuclear neutrophils. Immunol Today (1995) 16:21–26.
   PubMedGoogle Scholar
• MAGRAM J, CONNAUGHTON SE, WARRIER RR et al: 11-12-deficient mice are defective in IFN-y production and type 1 cytokine responses. Immunity (1996) 4:471–481.
   PubMed Web of Science ®Google Scholar
• COYLE AJ, TSUYUKI S, BERTRAND C et al: Mice lacking the IFN-y receptor have an impaired ability to resolve a lung eosinophilic inflammatory response associated with a prolonged capacity of T-cells to exhibit a Th2 cytokine profile. J. Immunol (1996) 156:2680–2685.
   PubMed Web of Science ®Google Scholar
• KRUG N, MADDEN J, REDINGTON AE eta].: T-cell cytokineprofile evaluated at the single cell level in BAL and blood in allergic asthma. Am. J. Resp. Cell Mot. Biol. (1996) 14:319–326.
   Google Scholar
• HOLTZMAN MJ, SAMPATH D, CASTRO M, LOOK DC, JAYARAMAN S: The one-two of T-helper cells: does interferon-y knock out the Th2 hypothesis of asthma? Am. J. Resp. Cell Mol. Biol. (1996) 14:316–318.
   PubMed Web of Science ®Google Scholar
• IWAMOTO I, NAKAJIMA H, ENDO H, YOSHIDS S: Inter-feron-y regulates antigen-induced eosinophil recruit-ment into the mouse airways by inhibiting the infiltration of CDe T-cells. J. Exp. Med. (1993) 177:573–580.
   PubMed Web of Science ®Google Scholar
• LACK G, RENZ H, SALOGA J et al: Nebulized but not pare nteralIFN-y decreases IgE production and normal-izes airways function in a murine model of allergen sensitization. J. Immunol (1994) 152:2546–2554.
   PubMed Web of Science ®Google Scholar
• BOGUNIEWICZ M, MARTIN RJ, MARTIN D et aL: The effects of nebulized recombinant interferon-y in asthmatic airways. J. Allergy Clin. Immunol. (1995) 95:133–135.
   PubMed Web of Science ®Google Scholar
• LI X-M, CHOPRA RK, CHOU T-Y et al: Mucosal IFN-y gene transfer inhibits pulmonary allergic responses in mice. Immunol. (1996) 157:3216–3219.
   Web of Science ®Google Scholar
• GAVETT SH, O'HEARN DJ, LI X et al: Interleukin-12 inhibits antigen-induced airway hyper -responsiveness, inflammation, and Th2 cytokine expression in mice. J. Exp. Med. (1995) 182:1527–1536.
   PubMed Web of Science ®Google Scholar
• KIPS JC, BRUSSELLE GJ, JOOS GF et al.: Interleukin-12 inhibits antigen-induced airway hyper-responsiveness in mice. Am. J. Resp. Grit Care Med. (1996) 153:535–539.
   PubMed Web of Science ®Google Scholar
• SUR S, LAM J, BOU CHARD P et al: Immunomodulatory effects of IL-12 on allergic lung inflammation depend on timing of doses. J. Immunol (1996) 157:4173–4180.
   PubMed Web of Science ®Google Scholar